STOCK TITAN

[Form 4] H.B. Fuller Company Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

H.B. Fuller Company (FUL) Executive VP & CFO John J. Corkrean reported changes in his beneficial ownership on Form 4. The filing shows a disposition of 52,196 shares of Common Stock on 08/15/2025. The report details derivative and equity holdings still held by the reporting person, including phantom units that convert 1-for-1 into common shares (159.84 units shown, representing 26,199.97 when combined with a dividend equivalent feature), multiple vested and unvested employee stock options with exercise prices ranging from $43.48 to $77.72 and individual option share counts listed (for example, 41,208, 48,309, 38,376 among others), and restricted stock units that vest in scheduled installments (examples: 1,292.02, 2,830.02, 4,335.92). The Form 4 is signed by an attorney-in-fact on behalf of the reporting person on 08/18/2025. The filing does not state a sale price for the 52,196-share disposition.

John J. Corkrean, Executive VP e CFO di H.B. Fuller Company (FUL), ha segnalato variazioni nella sua posizione patrimoniale tramite un Form 4. La comunicazione riporta la cessione di 52.196 azioni di Common Stock il 15/08/2025. Il documento elenca inoltre le posizioni in derivati e azioni ancora detenute dall'interessato, comprese unità fantasma convertibili 1-contro-1 in azioni ordinarie (159,84 unità, che corrispondono a 26.199,97 se sommate a un equivalente dividendo), numerose stock option dipendenti — vested e unvested — con prezzi di esercizio compresi tra $43.48 e $77.72 e conteggi di azioni per singola opzione (ad esempio 41.208, 48.309, 38.376), e unità di azioni vincolate (RSU) che maturano a rate programmate (esempi: 1.292,02, 2.830,02, 4.335,92). Il Form 4 è stato firmato da un procuratore in data 18/08/2025. La segnalazione non indica il prezzo di vendita relativo alla cessione delle 52.196 azioni.

John J. Corkrean, Vicepresidente Ejecutivo y CFO de H.B. Fuller Company (FUL), informó cambios en su titularidad beneficiaria mediante un Form 4. La presentación muestra una disposición de 52.196 acciones ordinarias el 15/08/2025. El informe detalla además posiciones en derivados y acciones que aún mantiene, incluidas unidades ficticias convertibles 1 a 1 en acciones comunes (159,84 unidades, que representan 26.199,97 al combinarse con el equivalente por dividendos), múltiples opciones sobre acciones (consolidada y no consolidada) con precios de ejercicio entre $43.48 y $77.72 y recuentos de acciones por opción (por ejemplo 41.208, 48.309, 38.376), y unidades restringidas que vencen en plazos programados (ejemplos: 1.292,02, 2.830,02, 4.335,92). El Form 4 fue firmado por un apoderado el 18/08/2025. La presentación no especifica el precio de venta de la disposición de 52.196 acciones.

H.B. Fuller Company(FUL)의 수석부사장이자 CFO인 John J. Corkrean이 Form 4를 통해 보유 변동을 신고했습니다. 제출서류에는 2025-08-15에 보통주 52,196주 처분이 기재되어 있습니다. 보고서는 또한 보고인이 여전히 보유한 파생상품 및 주식 보유를 상세히 적시하고 있는데, 배당 상당액을 포함하면 26,199.97에 해당하는 1대1 전환되는 팬텀 유닛 159.84단위, 행사가가 $43.48에서 $77.72 사이인 여러 개의 취득·미취득 스톡옵션(예: 41,208, 48,309, 38,376 등 개별 옵션별 주식 수 기재), 그리고 일정에 따라 귀속되는 제한주(RSU)(예: 1,292.02, 2,830.02, 4,335.92)가 포함되어 있습니다. Form 4는 2025-08-18에 대리인(법정대리인)에 의해 서명되었습니다. 제출서에는 52,196주 처분의 매각 가격은 명시되어 있지 않습니다.

John J. Corkrean, vice‑président exécutif et directeur financier de H.B. Fuller Company (FUL), a déclaré des changements dans sa détention bénéficiaire via un Form 4. Le dépôt indique une cession de 52 196 actions ordinaires le 15/08/2025. Le rapport détaille également les positions en dérivés et en actions encore détenues par le déclarant, y compris des unités fantômes convertibles 1 pour 1 en actions ordinaires (159,84 unités, représentant 26 199,97 une fois combinées avec un équivalent dividende), plusieurs options sur actions acquises et non acquises avec des prix d'exercice allant de $43.48 à $77.72 et des nombres d'actions par option (par exemple 41 208, 48 309, 38 376), ainsi que des unités d'actions restreintes (RSU) qui acquièrent des droits selon un calendrier (exemples : 1 292,02, 2 830,02, 4 335,92). Le Form 4 a été signé par un mandataire le 18/08/2025. Le dépôt ne précise pas le prix de vente pour la cession des 52 196 actions.

John J. Corkrean, Executive VP & CFO der H.B. Fuller Company (FUL), meldete Änderungen seiner wirtschaftlichen Beteiligung in einem Form 4. Die Einreichung weist eine Veräußerung von 52.196 Stück Common Stock am 15.08.2025 aus. Der Bericht listet außerdem noch vom Melder gehaltene Derivate und Aktien auf, darunter Phantom-Einheiten, die 1:1 in Stammaktien umwandelbar sind (159,84 Einheiten, was in Kombination mit einer Dividendenäquivalenz 26.199,97 ergibt), mehrere ausgeübte und nicht ausgeübte Mitarbeiteraktienoptionen mit Ausübungspreisen zwischen $43.48 und $77.72 und einzelne Optionsstückzahlen (z. B. 41.208, 48.309, 38.376), sowie Restricted Stock Units mit planmäßiger Vesting-Aufteilung (Beispiele: 1.292,02, 2.830,02, 4.335,92). Das Form 4 wurde am 18.08.2025 von einem Bevollmächtigten unterzeichnet. In der Meldung ist kein Verkaufspreis für die Veräußerung der 52.196 Aktien angegeben.

Positive
  • Transparent disclosure of a sizable insider share disposition and detailed listing of outstanding equity awards and vesting schedules
Negative
  • Disposition of 52,196 common shares on 08/15/2025 (sale price not disclosed in the filing)

Insights

TL;DR: Insider disposed of 52,196 shares; extensive remaining option and RSU position remains.

The disposal of 52,196 common shares on 08/15/2025 is the clearest actionable item for investors because it represents an actual reduction in direct common-share holdings by the Executive VP & CFO. The filing also enumerates numerous employee stock options (with exercise prices from $43.48 to $77.72) and restricted stock units that remain outstanding and subject to vesting schedules. Because no sale price for the disposed shares is reported on this form, valuation impact cannot be directly assessed from this filing alone. The detailed listing of derivative positions is useful for assessing potential future dilution if options are exercised or RSUs convert.

TL;DR: Form 4 properly discloses a significant share disposition and enumerates remaining equity awards and vesting terms.

The filing appears to comply with Section 16 reporting by identifying the reporting person, relationship to the issuer (Executive VP & CFO), transaction date (08/15/2025), and enumerating derivative securities, phantom units, options, and restricted stock units with vesting or exercisability dates. Notably, the report lacks a transaction price for the 52,196-share disposition, which limits transparency on proceeds or economic intent. The signature by an attorney-in-fact is included with date 08/18/2025, satisfying execution disclosure requirements.

John J. Corkrean, Executive VP e CFO di H.B. Fuller Company (FUL), ha segnalato variazioni nella sua posizione patrimoniale tramite un Form 4. La comunicazione riporta la cessione di 52.196 azioni di Common Stock il 15/08/2025. Il documento elenca inoltre le posizioni in derivati e azioni ancora detenute dall'interessato, comprese unità fantasma convertibili 1-contro-1 in azioni ordinarie (159,84 unità, che corrispondono a 26.199,97 se sommate a un equivalente dividendo), numerose stock option dipendenti — vested e unvested — con prezzi di esercizio compresi tra $43.48 e $77.72 e conteggi di azioni per singola opzione (ad esempio 41.208, 48.309, 38.376), e unità di azioni vincolate (RSU) che maturano a rate programmate (esempi: 1.292,02, 2.830,02, 4.335,92). Il Form 4 è stato firmato da un procuratore in data 18/08/2025. La segnalazione non indica il prezzo di vendita relativo alla cessione delle 52.196 azioni.

John J. Corkrean, Vicepresidente Ejecutivo y CFO de H.B. Fuller Company (FUL), informó cambios en su titularidad beneficiaria mediante un Form 4. La presentación muestra una disposición de 52.196 acciones ordinarias el 15/08/2025. El informe detalla además posiciones en derivados y acciones que aún mantiene, incluidas unidades ficticias convertibles 1 a 1 en acciones comunes (159,84 unidades, que representan 26.199,97 al combinarse con el equivalente por dividendos), múltiples opciones sobre acciones (consolidada y no consolidada) con precios de ejercicio entre $43.48 y $77.72 y recuentos de acciones por opción (por ejemplo 41.208, 48.309, 38.376), y unidades restringidas que vencen en plazos programados (ejemplos: 1.292,02, 2.830,02, 4.335,92). El Form 4 fue firmado por un apoderado el 18/08/2025. La presentación no especifica el precio de venta de la disposición de 52.196 acciones.

H.B. Fuller Company(FUL)의 수석부사장이자 CFO인 John J. Corkrean이 Form 4를 통해 보유 변동을 신고했습니다. 제출서류에는 2025-08-15에 보통주 52,196주 처분이 기재되어 있습니다. 보고서는 또한 보고인이 여전히 보유한 파생상품 및 주식 보유를 상세히 적시하고 있는데, 배당 상당액을 포함하면 26,199.97에 해당하는 1대1 전환되는 팬텀 유닛 159.84단위, 행사가가 $43.48에서 $77.72 사이인 여러 개의 취득·미취득 스톡옵션(예: 41,208, 48,309, 38,376 등 개별 옵션별 주식 수 기재), 그리고 일정에 따라 귀속되는 제한주(RSU)(예: 1,292.02, 2,830.02, 4,335.92)가 포함되어 있습니다. Form 4는 2025-08-18에 대리인(법정대리인)에 의해 서명되었습니다. 제출서에는 52,196주 처분의 매각 가격은 명시되어 있지 않습니다.

John J. Corkrean, vice‑président exécutif et directeur financier de H.B. Fuller Company (FUL), a déclaré des changements dans sa détention bénéficiaire via un Form 4. Le dépôt indique une cession de 52 196 actions ordinaires le 15/08/2025. Le rapport détaille également les positions en dérivés et en actions encore détenues par le déclarant, y compris des unités fantômes convertibles 1 pour 1 en actions ordinaires (159,84 unités, représentant 26 199,97 une fois combinées avec un équivalent dividende), plusieurs options sur actions acquises et non acquises avec des prix d'exercice allant de $43.48 à $77.72 et des nombres d'actions par option (par exemple 41 208, 48 309, 38 376), ainsi que des unités d'actions restreintes (RSU) qui acquièrent des droits selon un calendrier (exemples : 1 292,02, 2 830,02, 4 335,92). Le Form 4 a été signé par un mandataire le 18/08/2025. Le dépôt ne précise pas le prix de vente pour la cession des 52 196 actions.

John J. Corkrean, Executive VP & CFO der H.B. Fuller Company (FUL), meldete Änderungen seiner wirtschaftlichen Beteiligung in einem Form 4. Die Einreichung weist eine Veräußerung von 52.196 Stück Common Stock am 15.08.2025 aus. Der Bericht listet außerdem noch vom Melder gehaltene Derivate und Aktien auf, darunter Phantom-Einheiten, die 1:1 in Stammaktien umwandelbar sind (159,84 Einheiten, was in Kombination mit einer Dividendenäquivalenz 26.199,97 ergibt), mehrere ausgeübte und nicht ausgeübte Mitarbeiteraktienoptionen mit Ausübungspreisen zwischen $43.48 und $77.72 und einzelne Optionsstückzahlen (z. B. 41.208, 48.309, 38.376), sowie Restricted Stock Units mit planmäßiger Vesting-Aufteilung (Beispiele: 1.292,02, 2.830,02, 4.335,92). Das Form 4 wurde am 18.08.2025 von einem Bevollmächtigten unterzeichnet. In der Meldung ist kein Verkaufspreis für die Veräußerung der 52.196 Aktien angegeben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Corkrean John J

(Last) (First) (Middle)
1200 WILLOW LAKE BOULEVARD
P.O. BOX 64683

(Street)
ST. PAUL MN 55164-0683

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
FULLER H B CO [ FUL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Executive VP and CFO
3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 52,196 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Phantom Units $0.0000(1) 08/15/2025 A 159.84 (2) (2) Common Stock 159.84 $58.97 26,199.97(3) D
Employee Stock Option (Right-to-Buy) $43.48 05/17/2017(4) 05/17/2026 Common Stock 16,672 16,672 D
Employee Stock Option (Right-to-Buy) $45.05 01/24/2020(4) 01/24/2029 Common Stock 41,208 41,208 D
Employee Stock Option (Right-to-Buy) $48.35 01/24/2021(4) 01/24/2030 Common Stock 48,309 48,309 D
Employee Stock Option (Right-to-Buy) $50.1 01/26/2018(4) 01/26/2027 Common Stock 23,696 23,696 D
Employee Stock Option (Right-to-Buy) $51.89 01/27/2022(4) 01/27/2031 Common Stock 38,376 38,376 D
Employee Stock Option (Right-to-Buy) $53.57 01/25/2019(4) 01/25/2028 Common Stock 21,834 21,834 D
Employee Stock Option (Right-to-Buy) $64.28 01/27/2026(5) 01/27/2035 Common Stock 24,570 24,570 D
Employee Stock Option (Right-to-Buy) $68.17 01/24/2024(5) 01/24/2033 Common Stock 22,312 22,312 D
Employee Stock Option (Right-to-Buy) $72.94 01/24/2023(4) 01/24/2032 Common Stock 21,997 21,997 D
Employee Stock Option (Right-to-Buy) $77.72 01/26/2025(5) 01/26/2034 Common Stock 24,774 24,774 D
Restricted Stock Units $0.0000(6) 01/24/2024(7) 01/24/2026 Common Stock 1,292.02 1,292.02(8) D
Restricted Stock Units $0.0000(6) 01/26/2025(7) 01/26/2027 Common Stock 2,830.02 2,830.02(8) D
Restricted Stock Units $0.0000(6) 01/27/2026(7) 01/27/2028 Common Stock 4,335.92 4,335.92(8) D
Explanation of Responses:
1. These units (acquired after 12-31-04) convert into shares of common stock on a 1-for-1 basis.
2. These units (acquired after 12-31-04) convert into shares of common stock upon the earlier of certain termination events as specified in the Key Employee Deferred Compensation Plan or such earlier date as selected by the participant, subject to holding periods required by law.
3. Amount includes stock units acquired pursuant to a dividend equivalent feature.
4. This option is 100% vested.
5. This option vests in three annual installments (33%, 33%, and 34%) beginning on the date shown.
6. These restricted stock units convert into shares of common stock on a 1-for-1 basis.
7. These restricted stock units vest in three annual installments (33%, 33%, and 34%) beginning on the date shown.
8. Amount includes restricted stock units acquired pursuant to a dividend equivalent reinvestment feature.
/s/ Patrick J. Seul, Attorney-in-Fact 08/18/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider is reported on the Form 4 for FUL?

The reporting person is John J. Corkrean, listed as Executive VP and CFO.

What transaction is reported and when did it occur?

A disposition of 52,196 shares of Common Stock occurred on 08/15/2025.

Does the Form 4 show the sale price for the 52,196 shares?

No. The filing lists the disposition but does not state a sale price for the 52,196-share transaction.

What types of equity awards remain outstanding for the reporting person?

The filing lists phantom units that convert 1-for-1, multiple employee stock options with exercise prices from $43.48 to $77.72 and specified share counts (for example 16,672, 41,208, 48,309), and restricted stock units (example amounts: 1,292.02, 2,830.02, 4,335.92) with stated vesting schedules.

Who signed the Form 4 and when?

The Form 4 was signed by Patrick J. Seul, Attorney-in-Fact on 08/18/2025.
Fuller H B Co

NYSE:FUL

FUL Rankings

FUL Latest News

FUL Latest SEC Filings

FUL Stock Data

3.18B
53.77M
0.28%
98.7%
2.66%
Specialty Chemicals
Adhesives & Sealants
Link
United States
ST PAUL